Copyright: ©Author(s) 2026.
World J Diabetes. Jul 15, 2026; 17(7): 120448
Published online Jul 15, 2026. doi: 10.4239/wjd.120448
Published online Jul 15, 2026. doi: 10.4239/wjd.120448
Table 1 Summary of standard glucose-lowering agents and novel mechanism-targeted therapies that have demonstrated cardioprotective effects in diabetic cardiomyopathy or diabetes-associated cardiac injury
| Drug | Drug dosage | Model | Mechanisms |
| Canagliflozin | 20 mg/kg/day, i.g., 6 weeks; 10 μM, 24 hours | C57BL/6J mice; H9C2 cells under high glucose (35 mmol/L) | ↓oxidative stress & ferroptosis markers; ↓total iron & Fe²+ deposition; improves cardiac injury indices (DCM protection); ↓ROS/Lipid ROS; ↑ΔΨm; ↓iron overload/ferroptosis-related injury[112] |
| Canagliflozin | 10 or 30 mg/kg/day, i.g., 12 weeks; 5 μg/mL, 24 hours (with PA 0.1 mmol/L) | C57BL/6J mice; HL-1 cardiomyocytes lipotoxicity model | Activates PINK1-Parkin-dependent mitophagy; improves mitochondrial function (via AMPK phosphorylation noted)[114]; Activates AMPK; inhibits inflammation (COX-2/iNOS) and ferroptosis indicators in PA-treated cells[113] |
| Evogliptin | 100 mg/kg/day, i.g., 12 weeks | db/db mice | Improves systolic/diastolic function; reduces lipotoxicity; activates PGC-1α/NRF1/TFAM → mitochondrial biogenesis[117] |
| Liraglutide | 200 μg/kg/day (subcutaneous), 8 weeks | Diabetic rat model | Activates Nrf2/GPX4 signaling; ↓lipid peroxidation and ferroptosis-related myocardial injury[120] |
| Melatonin | 20 mg/kg/day, i.g., 4 weeks; 100 μmol/L, 4 hours | Parkin-/- mice (C57BL/6 background)-DCM model; Primary neonatal cardiomyocyte culture | Promotes Parkin translocation to mitochondria; increases LC3-II expression; enhances PINK1/Parkin-dependent mitophagy[130] |
| Alisporivir | 2.5 mg/kg/day, i.p., 20 days | C57BL/6NCrl line-DM model | Induces mitophagy via transcriptional upregulation of PINK1 and Parkin; reduces mitochondrial lipid peroxidation in Diabetic mouse heart tissue[131] |
| mito-TEMPO | 0.7 mg/kg/day, i.p., 30 days. 25 nmol/L, 24 hours | T1DM (C57BL/6 mice) and T2DM mouse (db/db mice) models; Adult mouse ventricle cardiomyocytes | Mitochondria-targeted ROS scavenger; reduces oxidative stress; prevents cardiomyocyte apoptosis and cardiac hypertrophy[132] |
| MitoGamide | 10 mg/kg, i.g., 10-12 weeks | Akita diabetic mice; Diabetic mouse heart | Mitochondria-targeted scavenging of MGO; reduced AGE formation; preservation of mitochondrial function and cardiac energetics; mitigation of oxidative stress[135,136] |
Table 2 Traditional Chinese medicine-derived bioactive compounds that ameliorate mitochondrial homeostasis disruption and ferroptosis
| Compounds | Herb source | Drug dosage | Model | Mechanisms | Clinical evidence |
| Resveratrol | Japanese knotweed, Reynoutria japonica Houtt. | 25-50 mg/kg i.g./i.p. (5-7 days); 20-50 μM in vitro | STZ-DCM mice; HG-H9c2 cells | Activating SIRT1 → PGC-1α increases mitochondrial biogenesis (↑mtDNA, ΔΨm, ATP). Additionally, activating the Nrf2-GPX4 axis confers anti-ferroptotic protection; in STZ-T1DM DCM mice, resveratrol (25 mg/kg/day, 12 weeks) ↓labile Fe/MDA, ↑GSH/GPX4, improved EF/FS, and restored mitochondrial ultrastructure[95,139,140] | Clinical studies and systematic reviews report improved insulin resistance, glycemic control, and oxidative stress (15 RCTs, 896 patients)[142-145] |
| Salidroside | Rhodiola, Rhodiola rosea L. | 1.5 g/kg/day i.g. for 5 weeks | db/db mice | Inhibits ferroptosis (↑GPX4; ↓serum iron, transferrin; trend ↓SLC7A11); modulates autophagy (↓LC3-II); improves myocardial ultrastructure[146] | |
| Salidroside | Rhodiola, Rhodiola rosea L. | 50-100 mg/kg/day, 16 weeks (oral gavage); 10 μM in vitro | HFD/STZ-DCM mice; NRCMs | Activates AMPK/Akt-SIRT3 → ↑PGC-1α, TFAM; promotes mitochondrial biogenesis; improves mitochondrial function[147] |
Table 3 Effects of traditional Chinese medicine-derived bioactive compounds on regulating mitochondrial dynamics in diabetic cardiomyopathy
| Compounds | Herb source | Drug dosage | Model | Mechanisms |
| Ginsenoside Rb1 | Ginseng, Panax ginseng C. A. Meyer | 50 mg/kg/day i.g.; 50-100 μM in vitro | db/db mice; PA-H9c2 cells | Upregulates Mfn2; promotes mitochondrial fusion; reduces oxidative stress and apoptosis; improves mitochondrial function[148] |
| Ophiopogon D | Dwarf lilyturf, Ophiopogon japonicus (Thunb.) Ker Gawl. | 5 mg/kg/day i.g. for 4 weeks; 1 μM, 5 μM, 10 μM in vitro | db/db mice; PA-H9c2 cells | Inhibits Drp1, restores MFN1/2 and OPA1; improves mitochondrial dynamics, reduces apoptosis, relieves lipotoxic injury[149] |
| Paeonol | Cortex Moutan, Paeonia suffruticosa Andr. | 75 mg/kg/day, 150 mg/kg/day, 300 mg/kg/day i.g.; 25 μM, 50 μM, 100 μM, 200 μM in vitro | STZ-DCM rats; HG-primary cardiomyocytes | Activates CK2α-Stat3 pathway; upregulates Opa1; promotes mitochondrial fusion; inhibits oxidative stress; improves cardiac function[150] |
| Perillaldehyde | Perilla, Perilla frutescens (L.) | 100 mg/kg/day, 200 mg/kg/day i.g., 20 μM in vitro | STZ-DCM rats; HG-H9c2 cells | Upregulates miR-133a-3p, inhibits GSK-3β; suppresses fibrosis (Col-I, Col-III, α-SMA); reduces apoptosis; improves mitochondrial dynamics (fusion/fission balance)[151] |
| Punicalagin | Pomegranate, Punica granatum L. | 30 mg/kg/day, 90 mg/kg/day i.g., 10 μM in vitro | STZ-DCM rats; HG-H9c2 cells | Inhibits PTP1B activity, increases Stat3 phosphorylation, upregulates Opa1, promotes mitochondrial fusion, improves mitochondrial function[152] |
| Rhein | Rhubarb (Rheum palmatum L.) | 120 mg/kg/day i.g.; 1 μg/mL in vitro | HFD/STZ-DCM mice; HG-NRCMs; H9c2 ClpP-KD | Improves mitochondrial dynamics (↓p-Drp1S616/Drp1, |
Table 4 Effects of traditional Chinese medicine-derived bioactive compounds on regulating mitophagy in diabetic cardiomyopathy
| Compounds | Herb source | Drug dosage | Model | Mechanisms |
| Fucoxanthin, FX | Brown seaweed, Undaria pinnatifida (Harvey) Suringar | 200 mg/kg/day, 1 μM in vitro | STZ-induced DCM rats; HG-treated H9c2 cells | Alleviates oxidative stress; restores mitophagy; reduces myocardial fibrosis and hypertrophy[154] |
| Heterophyllin B | Prince ginseng, Pseudostellaria heterophylla (Miq.) Pax | 8 mg/kg/day, 20 mg/kg/day, 0.1 μM, 0.5 μM, 1 μM, 5 μM, 10 μM, 50 μM, 100 μM in vitro | STZ-DCM mice; HG-H9c2 cells; HG-NRCMs | MAVS-mediated mitochondrial homeostasis; normalizes mitophagy/autophagic flux (LC3-II balanced, autolysosome↓); |
| Tanshinone IIA | Red sage (Danshen), Salvia miltiorrhiza Bunge | 10 mg/kg/day, 25 mg/kg/day | STZ-induced DCM rats | Enhances PINK1-Parkin-dependent mitophagy (↑PINK1, Parkin, Beclin-1, LC3II/I; ↓p62); increases LC3-COX IV colocalization; restores mitochondrial ultrastructure & function; improves cardiac function; lowers blood glucose[156] |
Table 5 Effects of traditional Chinese medicine-derived bioactive compounds on regulating mitochondrial biogenesis in diabetic cardiomyopathy
| Compounds | Herb source | Drug dosage | Model | Mechanisms |
| Ferulic acid | Angelica, Angelica sinensis (Oliv.) Diels | 25 mg/kg/day i.g.; 10-25 μM in vitro | HFD + HFru + STZ DCM rats; HG-H9c2 | Normalizes MAM (↓PACS2/IP3R2/FUNDC1/VDAC1); restores mitochondrial biogenesis, fusion & OxPhos[157] |
| Gypenosides | Gynostemma, Gynostemma pentaphyllum (Thunb.) Makino | 50 mg/kg/day, 100 mg/kg/day, 150 mg/kg/day (10 weeks, oral) | STZ-induced diabetic rats | Activates AMPK/Nrf2/HO-1 pathway; ↑ PGC-1α expression; enhances antioxidant defense; promotes mitochondrial biogenesis; improves cardiac function[158] |
| Icariin | Epimedium, Epimedium spp. | 30 mg/kg/day, 7.5 μmol/L, 15 μmol/L, 30 μmol/L | db/db mice; HG-treated primary neonatal mouse cardiomyocytes | Activates Apelin/Sirt3 signaling → ↑ mitochondrial proteins (PGC-1α, Mfn2, Cyt-b) → restores ΔΨm, reduces ROS, inhibits apoptosis, improves cardiac function[96] |
| Rosmarinic acid | Rosemary, Rosmarinus officinalis L. | 100 mg/kg/day (4 weeks, oral gavage) | STZ-induced DCM mice; HG-treated H9c2 cardiomyocytes | Activates SIRT1/PGC-1α pathway; improves mitochondrial function (↑ΔΨm, ↑ATP, ↓ROS); reduces apoptosis (↓cleaved caspase-3, ↓Bax; ↑Bcl2); ameliorates cardiac dysfunction[159] |
Table 6 Effects of traditional Chinese medicine-derived bioactive compounds on regulating iron metabolism and ferroptosis in diabetic cardiomyopathy
| Compounds | Herb source | Drug dosage | Model | Mechanisms |
| Andrographolide | Green chiretta, Andrographis paniculata (Burm.f.) Wall. ex Nees - Andrographolide | 1 mg/kg, 10 mg/kg, 20 mg/kg | STZ-DCM mice; HG-H9c2 cells | Regulates NOX/Nrf2 oxidative stress and NF-κB inflammation/apoptosis[165] |
| Astragaloside IV | Astragalus, Astragalus membranaceus (Fisch.) Bunge | 20 mg/kg/day, 40 mg/kg/day, 80 mg/kg/day (in vivo); 20 μmol/L, 40 μmol/L, 80 μmol/L (in vitro) | STZ-DCM rats, HG-H9c2 cells | ↓CD36-mediated lipid uptake; ↓iron overload & lipid peroxidation; ↓ferroptosis markers (ACSL4, PTGS2, MDA); ↑GPX4, SLC7A11; improves cardiac function[166] |
| Baicalin | Scutellaria baicalensis Georgi (Radix Scutellariae) | 100 mg/kg i.g.; 10 LM, 20 LM, and 30 LM in vitro | db/db mice; HG-stimulated cells | Enhances SIRT3 deSUMOylation via SENP1 → restores mitochondrial quality control → inhibits ferroptosis & apoptosis, protects against DCM[160] |
| Curcumin | Turmeric, Curcuma longa L. | 300 mg/kg/day i.g.; 10 μM in vitro | STZ-DCM rabbits; HG/Nor-H9c2 cells | Attenuates ferroptosis via Nrf2/GPX4/HO-1; reduces HG-induced injury[163] |
| Isoliquiritigenin | Chinese licorice, Glycyrrhiza uralensis Fisch. ex DC. | 10 mg/kg, 20 mg/kg i.g. every other day for 12 weeks; 10 μM, 20 μM in vitro | STZ-T1DM mice; HG-H9c2 cells | Enhances Nrf2 activity in high glucose-induced H9c2 cardiomyocyte models[162] |
| Luteolin | Chinese skullcap, Scutellaria baicalensis Georgi | 20 mg/kg i.g. for 15 weeks; 5 and 10 μM in vitro | STZ-DCM mice; HG-H9c2 cells | Enhances Nrf2 activity in high glucose-induced H9c2 cardiomyocyte models[161] |
| Paeoniflorin | Peony, Paeonia lactiflora Pall. | 20 mg/kg/day and 70 mg/kg/day in vivo; 11, 12-EET 1 μM in vitro | STZ-DCM rats; HG-H9c2 cells | Modulates gut microbiota (↑Lactobacillus, Akkermansia; |
| Schisandrol B | Chinese magnolia vine, Schisandra chinensis (Turcz.) Baill. | 12.5 mg/kg, 25 mg/kg (10 weeks) | HFD + STZ-induced diabetic mice, PA-H9C2 cells | Inhibits ferroptosis via p53/SLC7A11/GPX4 axis, improves myocardial lipid metabolism[167] |
| Sulforaphane | Broccoli (cruciferous vegetables), Brassica oleracea L. | 0.5 mg/kg/day (i.p., 12 weeks); 1-5 μM (HG-H9c2 cells) | STZ-DCM mice; HG-H9c2 cells | Regulates ferroptosis via AMPK/Nrf2[124] |
| Syringaresinol | Clove, Syzygium aromaticum (L.) Merr. & L. M. Perry | Administered i.g. every other day for 8 weeks | STZ-induced type 1 diabetic mice | Alleviates DCM, reduces fibrosis and oxidative stress by downregulating Keap1 and activating Nrf2-NQO1/HO-1[219] |
Table 7 Representative combinations of traditional Chinese medicine-derived bioactive compounds with cardioprotective potential in diabetic cardiomyopathy
| Compounds | Herb source | Drug dosage | Model | Mechanisms |
| Artemisinin + Allicin | Sweet wormwood, Artemisia annua L.; Garlic, Allium sativum L. | 75 + 40 mg/kg/day i.g., 4 weeks | STZ-induced diabetic rats | Additive inhibition of NF-κB signaling, improved cardiac function and fibrosis[169] |
| Chlorogenic acid + Ferulic acid | Japanese honeysuckle, Lonicera japonica Thunb.; Chinese angelica, Angelica sinensis (Oliv.) Diels | CGA (110 mg/kg/day and 55 mg/kg/day), and FA (110 mg/kg/day and 55 mg/kg/day) for 15 weeks; 2 μM CGA, 2 μM FA for 24 hours | C57BL/6J mice-DCM model; PA-induced H9c2 cell lipotoxic model | Attenuation of cardiomyocyte lipotoxicity and mitochondrial dysfunction via GCGR-associated metabolic signaling (involving PPARα and AMPK)[170] |
| Tilianin + Syringin | Moldavian balm, Dracocephalum moldavica L; Ginseng, Panax ginseng C. A. Meyer | Tilianin 60 mg/kg/day (i.p.), Syringin 50 mg/kg/day (i.p.), 8 weeks | STZ + HFD-induced DCM rats; HG-H9c2 cells | Activates PGC-1α/SIRT3 (↑SIRT3, ↑PGC-1α, ↑ATP, ↓ROS, restored ΔΨm); inhibits TLR4/NF-κB/NLRP3 inflammation; reduces apoptosis (↓Bax, cleaved caspase-3; ↑Bcl2)[168] |
Table 8 Application prospects of traditional Chinese medicine formulations in diabetic cardiomyopathy
| TCM formulation | Formulation composition | Drug dosage | Model | mechanisms |
| Ginseng Dingzhi decoction | Ginseng, Panax ginseng C. A. Meyer; Atractylodes macrocephala, Atractylodes macrocephala Koidz.; Poria cocos, Poria cocos (Schw.) Wolf; Chinese yam, Dioscorea opposita Thunb.; Xylooligosaccharides | 30 g/kg/day, 15 days | TAC-induced heart failure mice; high-glucose-treated HL-1 cells | Mediated inflammation and cardiomyocyte apoptosis; reduces mitochondrial ROS accumulation and restores redox balance; preserves mitochondrial homeostasis and energy metabolism; promotes TMBIM6-dependent PINK/Parkin-mediated mitophagy and suppresses excessive mitochondrial fission; ultimately attenuates myocardial fibrosis and improves cardiac function after TAC[171] |
| Fufang Zhenzhu Tiaozhi | Ligustri lucidi fructus, Citri sarcodactylis fructus, Eucommiae cortex, Atractylodis macrocephalae rhizoma, Salviae miltiorrhizae radix et rhizoma, Notoginseng radix et rhizoma, Coptidis rhizome and Cirsii japonici herba et radix | 0.6 g/kg/day, 1.2 g/kg/day, and 2.4 g/kg/day, 12 weeks | C57BL/6J diabetic mice | Regulates myocardial lipid metabolism and mitochondrial dynamics (↓CD36, ↓mitochondrial lipid overload; ↓Drp1-mediated fission, ↑mitochondrial fusion; ↑mitochondrial energy metabolism); attenuates lipotoxicity-induced apoptosis (↓Bax, ↓cleaved caspase-3; ↓TUNEL-positive cells)[172] |
| Taohuajing | Persicae Semen [Prunus persica (L.) Batsch], Polygonatum sibiricum Delar. ex Redouté, and Carthami Flos (Carthamus tinctorius L.) | 0.125 g/kg/day, 0.25 g/kg/day, and 0.5 g/kg/day, 12 weeks | C57BL/6 J mice with DCM | Activates SIRT1-mediated antioxidant defense (↑SIRT1, ↑GSH-Px, ↑SOD; ↓ROS, ↓MDA); suppresses NLRP3 inflammasome-driven inflammation (↓NLRP3, ↓pro-inflammatory cytokines); attenuates oxidative stress- and inflammation-induced cardiac dysfunction and fibrosis in DCM |
| YuNü-Jian | Rehmanniae Radix [Rehmannia glutinosa (Gaertn.) DC.]; Anemarrhenae Rhizoma (Anemarrhena asphodeloides Bunge); Gypsum Fibrosum; Ophiopogonis Radix | 4.52 g/kg/day, 10 weeks | Male SD rats with T2DM | Activates the SIRT1-Nrf2-NQO1 antioxidant axis (↑SIRT1, ↑Nrf2, ↑NQO1, ↑SOD, ↑GSH-Px; ↓ROS, |
| Ling-Gui-Zhu-Gan decoction | Poria [Poria cocos (Schw.) Wolf]; Cinnamomi ramulus [Cinnamomum cassia (L.) J. Presl]; Atractylodis Macrocephalae Rhizoma (Atractylodes macrocephala Koidz.); Glycyrrhizae Radix et Rhizoma (Glycyrrhiza uralensis Fisch.) | 2.1 g/kg/day, 4.2 g/kg/day, and | HFD-induced metabolic cardiomyopathy model-SD rats | r Reduces excessive fatty acid uptake and lipid deposition; Regulates PLIN5-dependent lipid droplet homeostasis; Suppresses lipid peroxidation-driven ferroptosis (↓ACSL4, ↓MDA, ↓lipid peroxidation; ↑GPX4, ↑FPN1, ↑SOD); Preserves mitochondrial structure and function; Attenuates cardiomyocyte injury and cardiac remodeling[175] |
- Citation: Tang YT, Wu Q, Chen YP, Xia L, Yang MH, Wei MY, Pang Q, Yang YN, Liu JB, Liu JL, Ni Q, Gong YB. Regulation of ferroptosis and mitochondrial homeostasis disruption in diabetic cardiomyopathy: Therapeutic potential of traditional Chinese medicine. World J Diabetes 2026; 17(7): 120448
- URL: https://www.wjgnet.com/1948-9358/full/v17/i7/120448.htm
- DOI: https://dx.doi.org/10.4239/wjd.120448